Federal award
QUIDELORTHO SALES COMPANY, LLC
FA452821P0016
Contract
Obligated and Ceiling
- Obligated (net)
- $205,829.77
- Ceiling (potential value, not spending)
- $205,829.77
- Current value
- $205,829.77
- Gross positive obligations
- $207,535.12
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Awarding agency
- Department of War · sub-agency 5700 · office FA4528
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA452821P0016
- Award type code
- B
- Actions
- 15 · Mar 31, 2021 to Feb 13, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History15
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 13, 2026 | FY2026 | P00014 | J | $0.00 | — |
| Jun 9, 2025 | FY2025 | P00013 | B | −$413.97 | — |
| Apr 15, 2025 | FY2025 | P00012 | B | $0.00 | — |
| Mar 28, 2025 | FY2025 | P00011 | M | $0.00 | — |
| Mar 18, 2025 | FY2025 | P00010 | G | $46,403.38 | — |
| Feb 28, 2025 | FY2025 | P00009 | B | $0.00 | — |
| Jan 29, 2025 | FY2025 | P00008 | B | $14,427.26 | — |
| Jan 14, 2025 | FY2025 | P00007 | D | −$1,263.48 | — |
| Mar 1, 2024 | FY2024 | P00006 | D | $31,976.12 | — |
| May 3, 2023 | FY2023 | P00005 | D | −$27.90 | — |
| Feb 8, 2023 | FY2023 | P00004 | G | $31,976.12 | — |
| Aug 16, 2022 | FY2022 | P00003 | B | $11,000.00 | — |
| Mar 25, 2022 | FY2022 | P00002 | G | $31,976.12 | — |
| Feb 9, 2022 | FY2022 | P00001 | B | $7,800.00 | — |
| Mar 31, 2021 | FY2021 | 0 | — | $31,976.12 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.